August 5, 2021
“NexPoint Real Estate Finance (NREF)… There are only two recent reviews on record for NREF shares, but they both agree – this is a stock to buy. Their agreement gives the shares their Moderate Buy consensus rating. NREF is trading for… Continue Reading…
March 23, 2021
“Iovance Biotherapeutics (IOVA)… The cutting edge med tech has attracted attention from Pantginis’ colleagues, as well. The stock has 5 recent reviews, and all are to Buy, making for a unanimous Strong Buy analyst consensus rating. IOVA has an average… Continue Reading…
February 11, 2021
“Village Farms International (VFF)… Overall, there are 3 recent reviews on VFF shares, and all are Buys, giving the stock a Strong Buy analyst consensus rating and showing a general agreement on Wall Street about the company’s strengths. Shares are… Continue Reading…
January 20, 2021
“Ready Capital Corporation (RC)… There are two recent reviews of Ready Capital and both are Buys, giving the stock a Moderate Buy consensus rating. Shares in this REIT are selling for $11.57 while the average price target stands at $13.63, indicating… Continue Reading…
January 6, 2021
“17 Education & Technology (YQ)… The Goldman review is one of two on record for 17 Education; the other is also a Buy, making the consensus view a Moderate Buy. The stock is priced at $13.5, and the $20.50 average… Continue Reading…
December 31, 2020
“New Residential Investment (NRZ)… It’s not often that the analysts all agree on a stock, so when it does happen, take note. NRZ’s Strong Buy consensus rating is based on a unanimous 8 Buys. The stock’s $11.36 average price target… Continue Reading…
December 14, 2020
“Vertex Pharmaceuticals (VRTX)… Overall, it appears that Wall Street agrees with Tenthoff. VRTX shares have a Strong Buy analyst consensus rating, based on 14 Buys and 4 Holds. The stock’s $287.50 average price target suggests it has room for 24% growth… Continue Reading…
December 8, 2020
“Baxter International (BAX)… Overall, the analyst consensus rating on Baxter is a Strong Buy, based on 12 reviews that include 11 Buys against just a single Hold. The stock is selling for $78, and its $95 average price target suggest it… Continue Reading…
December 3, 2020
“Cinedigm Corporation (CIDM)… Currently, CIDM has 2 reviews on record, making the stock a Moderate Buy. The shares are selling for 53 cents, and the $2.75 average price target suggests an impressive 418% upside on the one-year time horizon… Kubient (KBNT)… To… Continue Reading…
December 3, 2020
“Nomad Foods (NOMD)… Overall, Nomad has 6 recent reviews, breaking down in a 5-to-1 split of Buy versus Hold. This makes the analyst consensus view a Strong Buy. The average price target is $28.33, for a 19% one-year upside from… Continue Reading…
Recent Comments